| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Frazier Life Sciences Public Fund, L.P. is a 10% Owner at Viridian Therapeutics, Inc.\DE. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $24.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | VRDN Viridian Therapeutics, Inc.\de | 10% Owner | Buy | 200,000 | $11.00 | $2,200,000.00 | +15.3% | +45.2% | +43.8% |